by Datwriterguy | Aug 10, 2019 | Premium Press Releases
New York, NY, August 10, 2019 – Quantum Genomics are the creators of Firibastat, a first-in-class brain aminopeptidase inhibitor (BAPAI) that could potentially treat treatment-resistant hypertension by acting in the brain to interfere with the renin-angiotensin...